Wilson Sonsini is pleased to sponsor INTRO Life Sciences.

Join us for a conversation with Sarah Benson-Konforty, MD, a serial entrepreneur and physician turned investor and AI evangelist.

Sarah will share her insights on the fundamental shift in drug discovery as biology becomes computable and AI emerges as a new operating system for medicine. She will explore how machine learning is transforming target discovery, molecular design, and clinical strategy—moving the field beyond trial-and-error toward systems-level reasoning. Drawing on real-world case studies, it separates genuine breakthroughs from hype and highlights where AI is creating durable scientific and economic advantage. We will also learn what AI-native biotech companies will look like—and why they will outperform traditional models.

Agenda

• 6:30 PM – 6:45 PM – Registration
• 6:45 PM – 6:50 – Welcome Remarks by Hin Au, Patents & Innovations
• 6:50 – 8:00 PM – Speaker Presentation by Sarah Benson-Konforty, MD
• 8:00 PM – 9:00 PM – Networking

INTRO Life Sciences is an Israeli based network in the San Francisco Bay Area for life science and biotech professionals – including biology, chemistry, physics, materials sciences, etc. The mission of the group is to promote the local Israeli life science and bio-tech community by providing a platform for interaction and collaboration between the Israeli members, with the Silicon Valley professional community and its leaders.